Phase II study of vegf inhibitor, PTK787/ZK222584, in patients with refractory or relapsed diffuse large b-cell lymphoma

Category Primary study
JournalBlood
Year 2012
This article has no abstract
Epistemonikos ID: e5899e63e80bb4444b5a4e8b62d98b9920db0391
First added on: Feb 05, 2025